GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a truly shift in how we treat type 2 diabetes . These new drugs function to mimicking the body’s own GLP-1 process, which promotes glucose https://hotbookmarkings.com/story21739591/glp-1-a-major-advance-in-diabetes-care